Keywords: Perrigo, Cobrek Pharma, M&A, Foam-based generic drugs

Perrigo buys full control of Cobrek Pharma for about $45 million

Article | 31 December 2012

Print This

US drugmaker Perrigo (Nasdaq: PRGO; TASE) announced on Friday that it has signed a definitive merger agreement and has completed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in